Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 31 to 40 of 51 resources
-
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
These EASL Clinical Practice Guidelines (CPGs) are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the optimal management of patients with acute and chronic HCV infections. These guidelines apply to therapies that are approved at the time of their publication.UK, Rest of World 2014 Training, Reports & Research, Tools & Templates PDF -
Public Health England (PHE) Commissioning template for estimated HCV prevalence and numbers eligible for treatment by Drug Action Team Area (Excel Spreadsheet, 194 KB)This template has been produced by Public Health England (PHE) to help Local Authorities (LA) and Health and Wellbeing Boards estimate the prevalence of hepatitis C virus (HCV) infection in their local population, and the likely disease burden and associated treatment costs.UK 28 Feb 2014 Tools & Templates MS Excel
-
Hepatitis C adult services commissioning toolkit
This toolkit, designed by HCV Action, aims to support commissioners of hepatitis C services to commission for the high level outcomes set out in the new NHS22 and Public Health Outcomes Frameworks:23.UK Sep 2013 Tools & Templates, Strategy & Planning PDF -
The Hepatitis C Adult Services Commissioning Toolkit
This poster, produced by HCV Action, lays out our toolkit for the commissioning of adult services for hepatitis C patients.England 2013 Tools & Templates, Strategy & Planning PDF -
NICE public health guidance 43: Hepatitis B and C - ways to promote and offer testing to people at increased risk of infection
This guidance for commissioners and providers of public services aims to ensure more people at increased risk of hepatitis B and C infection are tested. The recommendations cover awareness-raising; testing; contact tracing; providing and auditing neonatal hepatitis B vaccination; commissioning hepatitis B and C testing and treatment services; and laboratory services for hepatitis B and C testing. This guidance, produced in 2012, was last modified in March 2013.UK Dec 2012 Tools & Templates, Strategy & Planning PDF -
Guidance on testing for hepatitis B and C (with reference to HIV) Developed by Yorkshire and the Humber Hepatitis B and C Steering Group
Individuals with chronic hepatitis (B and C) can be treated, which reduces the likelihood of chronic illness and premature death. Recognition of infection and treatment may also reduce the spread of infection. In 2010 across Yorkshire and the Humber there were 427 cases of hepatitis B (of which 39 were acute) and 980 newly identified hepatitis C infections reported through NHS/HPA laboratory testing, however HPA estimates calculate that there are over 20,000 people actually infected with hepatitis C in the region.Yorkshire and the Humber Mar 2012 Tools & Templates, Strategy & Planning PDF -
Hepatitis C - Treatment and follow-up
Valid until May 2014, this document provides a map of medicine for the treatment and follow-up of Hepatitis C.England 06 Jun 2011 Training, Tools & Templates PDF -
Tackling Blood-Borne Viruses in Prisons: A framework for best practice in the UK
This framework is intended to be a practical resource for those who have responsibility for the health and well being of prisoners and prison staff in the UK. In particular this is aimed at Healthcare Managers within the prison service; although it will also be relevant to Prison Governors, voluntary organisations and other providers delivering services in prisons.UK May 2011 Tools & Templates, Strategy & Planning PDF -
Hepatitis C - secondary care assessment
Valid until May 2014, this document provides a map of medicine for secondary care assessment of Hepatitis C.England 29 Apr 2011 Tools & Templates PDF -
Standards for Local Surveillance and Follow Up of Hepatitis B and C
These standards, produced by the Health Protection Agency in 2011, recognise that the detection and clinical management of hepatitis B and C can involve a number of health professionals, creating a diversity of clinical pathways. The development of the standards has also taken into account the fact that the prevalence of both hepatitis B and C varies markedly across the country and that current systems for the surveillance and follow up of cases also vary.UK 2011 Reports & Research, Tools & Templates, Strategy & Planning PDF